The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-N-{4-[3-(3-oxo-1H-pyrrolo[3,4-b]quinolin-2(3H)-yl)prop-1-enyl]phenyl}aceticacid ID: ALA2283029
PubChem CID: 76327219
Max Phase: Preclinical
Molecular Formula: C22H18N2O3
Molecular Weight: 358.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)Cc1ccc(/C=C/CN2Cc3cc4ccccc4nc3C2=O)cc1
Standard InChI: InChI=1S/C22H18N2O3/c25-20(26)12-16-9-7-15(8-10-16)4-3-11-24-14-18-13-17-5-1-2-6-19(17)23-21(18)22(24)27/h1-10,13H,11-12,14H2,(H,25,26)/b4-3+
Standard InChI Key: SINZJQVVUKDQDA-ONEGZZNKSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-1.0923 0.6397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0912 -0.1880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3877 -0.5970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3859 1.0480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3269 0.6361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3276 -0.1839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0361 -0.5910 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0306 1.0513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7397 0.6457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7428 -0.1817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5271 -0.4333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0088 0.2356 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5221 0.9001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7825 -1.2096 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8260 0.2407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2373 -0.4681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0544 -0.4650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4657 -1.1712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0574 -1.8766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4680 -2.5823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2860 -2.5796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6917 -1.8654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2788 -1.1626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6983 -3.2852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5154 -3.2810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9204 -2.5712 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9277 -3.9866 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 2 0
9 8 2 0
8 5 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 9 1 0
11 14 2 0
12 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 24 1 0
24 25 1 0
25 26 2 0
25 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 358.40Molecular Weight (Monoisotopic): 358.1317AlogP: 3.53#Rotatable Bonds: 5Polar Surface Area: 70.50Molecular Species: ACIDHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.45CX Basic pKa: 1.23CX LogP: 3.54CX LogD: 0.69Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.76Np Likeness Score: -0.11
References 1. Nagarapua L, Gaikwad HK, Manikonda SR, Bantu R, Manda KM, Kalivendi SV. (2013) Synthesis of novel building blocks of 1H-pyrrolo[3,4-b]quinolin-3(2H)-one and evaluation of their antitumor activity, 22 (1): [10.1007/s00044-012-0018-x ]